Virtus Fund Advisers, LLC Adma Biologics, Inc. Transaction History
Virtus Fund Advisers, LLC
- $20.2 Million
- Q3 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 10,478 shares of ADMA stock, worth $179,697. This represents 1.03% of its overall portfolio holdings.
Number of Shares
10,478
Previous 14,058
25.47%
Holding current value
$179,697
Previous $157,000
33.12%
% of portfolio
1.03%
Previous 0.63%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$320 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$311 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$223 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$216 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$147 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.37B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...